Jun 08, 2023 / 08:00PM GMT
Srishti Kotiyal - Jefferies - Analyst
-- Jefferies Global Healthcare Conference. My name is Srishti Kotiyal with the Jefferies Investment Banking team. And it is my great pleasure to introduce Talat Imran, CEO, Rani Therapeutics.
Talat Imran - Rani Therapeutics Holdings, Inc. - CEO
Thank you so much. Can you hear me? Where's the clicker? Is it -- it's up there. Should I go up there? I think so. I can't see --
Unidentified Participant
Go ahead. Now you can see it.
Talat Imran - Rani Therapeutics Holdings, Inc. - CEO
Now I can see it. There we go. Hey, can everybody hear me? No? Sorry about that. Appreciate it. I think I'm the last presentation between you and cocktail hour, so I'll move this along as quickly as I can. Thank you so much for making the time and thank you to Jefferies for allowing us the opportunity to present.
As Shrishti said, my name is Talat Imran, I'm the CEO of Rani Therapeutics. Joined by our CFO, Svai Sanford. Rani Therapeutics is a clinical-stage
Rani Therapeutics Holdings Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers